Commonly encountered dysregulation in mineral metabolism during AKI includes hypocalcemia, hyperphosphatemia, elevated parathyroid hormone (PTH), decreased 1,25-dihydroxyvitamin D (1,25D), elevated fibroblast growth factor 23 (FGF23), and decreased klotho. The gene discussed is PTH; the disease is acute kidney injury.